Position in INCY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,153,191,746
-$156,670,511 QoQ
Shares Held
12,252,356
-7.6% QoQ
Ownership
6.13%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Dodge & Cox holds $6,385,523,643 across 5 Biotechnology names. INCY ranks #2 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,458,238 | $3,444,613,008 | |
| 2 | INCY |
Incyte Corp
This page
|
12,252,356 | $1,153,191,746 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
14,561,759 | $822,593,765 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,929,253 | $638,331,940 | |
| 5 | BNTX |
BioNTech SE
|
3,676,791 | $326,793,184 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,153,191,746 | 12,252,356 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,309,862,257 | 13,261,742 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,181,608,200 | 13,932,416 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $993,931,826 | 14,595,181 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $900,035,060 | 14,864,328 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,030,499,051 | 14,919,633 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,009,749,747 | 15,276,093 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $926,233,772 | 15,279,343 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $878,251,969 | 15,416,043 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,010,317,534 | 16,090,421 | Shares | Sole | 2024-02-22 | |
| 2023-09-30 | $948,358,732 | 16,416,111 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,200,053,010 | 19,277,960 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,397,146,043 | 19,332,310 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,555,230,939 | 19,362,935 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,319,032,176 | 19,793,400 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,524,554,184 | 20,067,845 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,434,348,231 | 18,060,290 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,222,666,812 | 16,657,586 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,133,249,268 | 16,476,436 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,143,960,703 | 13,597,536 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $350,874,447 | 4,317,392 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $282,905,059 | 3,252,530 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $295,148,667 | 3,288,931 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $381,959,787 | 3,673,750 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $292,378,098 | 3,992,600 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||